Literature DB >> 19906032

Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient.

Maria M Zanone1, Enrica Favaro, Roberto Quadri, Ilaria Miceli, Fulvia Giaretta, Renato Romagnoli, Ezio David, Paolo Cavallo Perin, Mauro Salizzoni, Giovanni Camussi.   

Abstract

Association of type 1 diabetes and cytomegalovirus (CMV) is suspected and CMV infections have also been linked to increased risk of new onset post-transplantation diabetes. We monitored response to islet autoantigens, pancreatic endocrine function, and CMV infections in one type 1 diabetic patient receiving pancreas allograft. Time course analyses of levels of islet autoantibodies (Abs), IFN-gamma ELISPOT response, analysis of T cell function, levels of C peptide together with CMV pp65 antigenaemia and viraemia and graft biopsy histopathology were performed in comparison with a cohort of diabetic recipients. Evidence of autoimmune activation to GAD and IA2, modification of CD4(+) CD25hi T cells, loss of pancreatic function, concomitantly with multiple CMV infections and allograft rejection with peri-insulitis is provided. The parallel between metabolic outcome, initiation and progression of autoreactivity to islet autoantigens and early CMV infections after transplantation, suggests that persistent CMV infections may be relevant to the pathogenesis of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906032     DOI: 10.1111/j.1432-2277.2009.00994.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

Authors:  Ana M Sanchez; Wes Rountree; Mark Berrong; Ambrosia Garcia; Alexandra Schuetz; Josephine Cox; Nicole Frahm; Mark Manak; Marcella Sarzotti-Kelsoe; M Patricia D'Souza; Thomas Denny; Guido Ferrari
Journal:  J Immunol Methods       Date:  2014-03-28       Impact factor: 2.303

2.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

4.  Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.

Authors:  Tadahiro Uemura; Varun Ramprasad; Kazuhide Matsushima; Hiroko Shike; Tracy Valania; Osun Kwon; Nasrollah Ghahramani; Riaz Shah; Umar Farooq; Akhtar Khan; Zakiyah Kadry
Journal:  Transplantation       Date:  2011-09-27       Impact factor: 4.939

Review 5.  The generation and maintenance of serum alloantibody.

Authors:  M R Clatworthy; M Espeli; N Torpey; K G C Smith
Journal:  Curr Opin Immunol       Date:  2010-10       Impact factor: 7.486

6.  Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection.

Authors:  Morteza Izadi; Mojgan Fazel; Reza Karbasi-Afshar; Seyed Hassan Saadat; Mohammad Hassan Nasseri; Nematollah Jonaidi-Jafari; Reza Ranjbar; Davood Kazemi-Saleh
Journal:  ARYA Atheroscler       Date:  2014-05

7.  Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease.

Authors:  Kine Edvardsen; Alexander Hellesen; Eystein S Husebye; Eirik Bratland
Journal:  J Transl Med       Date:  2016-03-09       Impact factor: 5.531

8.  Prevalence of seropositivity of selected herpesviruses in patients with multiple sclerosis in the North of Jordan.

Authors:  Raid M Kofahi; Hassan M Kofahi; Suhib Sabaheen; Majdi Al Qawasmeh; Aiman Momani; Ahmed Yassin; Kefah Alhayk; Khalid El-Salem
Journal:  BMC Neurol       Date:  2020-10-29       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.